Agoracom: Small Cap Investment - Zenith Epigenetics

No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Stock2740

Rank: Treasurer [?]

Points: 330 [?]

Votes: 10 Score: 2.2 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

prostate drug

posted on Jan 09, 2016 08:40AM

https://en.m.wikipedia.org/wiki/Enzalutamide Target prostrate cancer with combo lead drug ZEN-3694 Stock

2 Recommendations

Jan 09, 2016 08:53AM

Jan 09, 2016 08:59PM

Back To Forum List View

Please to post a reply